Episode 64: New Frontiers in Submacular Hemorrhage: Insights from Ophthalmologica
In this episode, Prof. Martin Zinkernagel and Dr. Matias Iglicki spotlight Ophthalmologica’s new article collection on submacular hemorrhages. They explore key findings from four studies covering imaging, surgical strategies, and real-world outcomes, offering timely insights into managing this vision-threatening condition.
Ever considered broadening your professional horizons with an ophthalmology fellowship abroad? In this insightful episode, Dr. Peter Kiraly (Manchester Royal Eye Hospital) and Dr. Elon van Dijk (Leiden University Medical Center and Rotterdam Eye Hospital) share their personal journeys and practical advice from fellowships in the UK and Australia. Chaired by Jonathan McCrea
--------
28:13
--------
28:13
Episode 62: Bridging the Gap: How to Make Smarter Ocular Oncology Referrals
When should you refer and what should you include? Oncologists Hibba Quhill, Iwona Rospond-Kubiak, and Emine Kilic share practical, experience-based advice on improving referral pathways in ocular oncology. From triage strategies to imaging essentials, this episode covers what referring clinicians need to know to ensure timely and effective patient care
--------
22:01
--------
22:01
Episode 61: Personalising Anti-VEGF Treatment in Neovascular AMD: Does Phenotype Matter?
Dr. Sarah Mrejen (France), Associate Professor Salomon Cohen (France), and Associate Professor Dinah Zur (Israel) explore how neovascular AMD phenotype may influence imaging choices, patient dialogue, and treatment plans. From proactive vs. conservative strategies to new anti-VEGF agents and PCV diagnosis, this expert-led discussion offers key insights into personalising care in retinal disease.
--------
36:41
--------
36:41
Episode 60: Pregnancy, Retina, and Uveitis: Striking the Balance in Challenging Cases
Prof. Zohar Habot-Wilner (Tel Aviv University) chairs a rich discussion with Prof. Sofia Androudi (University of Thessaly, Greece) and Prof. Sarah Touhami (University of Sorbonne) on managing retinal and uveitic diseases during pregnancy. They explore safe diagnostic tools, therapeutic dilemmas like Ranibizumab vs. Ozurdex, and the effects of pregnancy-related hormonal shifts—highlighting the importance of multidisciplinary collaboration in high-risk cases
Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.
Ireland